150 related articles for article (PubMed ID: 24462801)
41. Role of catalase in the virulence of Brucella melitensis in pregnant goats.
Gee JM; Kovach ME; Grippe VK; Hagius S; Walker JV; Elzer PH; Roop RM
Vet Microbiol; 2004 Aug; 102(1-2):111-5. PubMed ID: 15288933
[TBL] [Abstract][Full Text] [Related]
42. Pathogenesis of placentitis in the goat inoculated with Brucella abortus. II. Ultrastructural studies.
Anderson TD; Cheville NF; Meador VP
Vet Pathol; 1986 May; 23(3):227-39. PubMed ID: 3088810
[TBL] [Abstract][Full Text] [Related]
43. Brucella-induced abortions and infection in bottlenose dolphins (Tursiops truncatus).
Miller WG; Adams LG; Ficht TA; Cheville NF; Payeur JP; Harley DR; House C; Ridgway SH
J Zoo Wildl Med; 1999 Mar; 30(1):100-10. PubMed ID: 10367651
[TBL] [Abstract][Full Text] [Related]
44. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis.
Navarro E; Segura JC; Castaño MJ; Solera J
Clin Infect Dis; 2006 May; 42(9):1266-73. PubMed ID: 16586386
[TBL] [Abstract][Full Text] [Related]
45. A new variant of Brucella melitensis.
Lucero NE; Ayala SM; Escobar GI; Grayon M; Jacques I
Clin Microbiol Infect; 2006 Jun; 12(6):593-6. PubMed ID: 16700714
[TBL] [Abstract][Full Text] [Related]
46. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
[TBL] [Abstract][Full Text] [Related]
47. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
48. Isolation and molecular characterization of Brucella melitensis from seropositive goats in Peninsula Malaysia.
Bamaiyi PH; Hassan L; Khairani-Bejo S; Zainal Abidin M; Ramlan M; Krishnan N; Adzhar A; Abdullah N; Hamidah N HM; Norsuhanna MM; Hashim SN
Trop Biomed; 2012 Dec; 29(4):513-8. PubMed ID: 23202595
[TBL] [Abstract][Full Text] [Related]
49. Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections.
Rajashekara G; Glover DA; Krepps M; Splitter GA
Cell Microbiol; 2005 Oct; 7(10):1459-73. PubMed ID: 16153245
[TBL] [Abstract][Full Text] [Related]
50. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens.
Ramamoorthy S; Sanakkayala N; Vemulapalli R; Jain N; Lindsay DS; Schurig GS; Boyle SM; Sriranganathan N
Int J Parasitol; 2007 Nov; 37(13):1531-8. PubMed ID: 17575983
[TBL] [Abstract][Full Text] [Related]
51. Mucosal bacterial dissemination in a rhesus macaque model of experimental brucellosis.
Russell-Lodrigue KE; Killeen SZ; Ficht TA; Roy CJ
J Med Primatol; 2018 Feb; 47(1):75-77. PubMed ID: 28573738
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.
Atkins HS; Spencer S; Brew SD; Jenner DC; Sefton AM; MacMillan AP; Brooks TJ; Simpson AJ
Int J Antimicrob Agents; 2010 Jul; 36(1):66-8. PubMed ID: 20022474
[TBL] [Abstract][Full Text] [Related]
53. The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection.
Fretin D; Fauconnier A; Köhler S; Halling S; Léonard S; Nijskens C; Ferooz J; Lestrate P; Delrue RM; Danese I; Vandenhaute J; Tibor A; DeBolle X; Letesson JJ
Cell Microbiol; 2005 May; 7(5):687-98. PubMed ID: 15839898
[TBL] [Abstract][Full Text] [Related]
54. Single tube identification and strain typing of Brucella melitensis by multiplex PCR.
Rees RK; Graves M; Caton N; Ely JM; Probert WS
J Microbiol Methods; 2009 Jul; 78(1):66-70. PubMed ID: 19410609
[TBL] [Abstract][Full Text] [Related]
55. Brucellosis in a mother and her young infant: probable transmission by breast milk.
Palanduz A; Palanduz S; Güler K; Güler N
Int J Infect Dis; 2000; 4(1):55-6. PubMed ID: 10689217
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.
Kahl-McDonagh MM; Elzer PH; Hagius SD; Walker JV; Perry QL; Seabury CM; den Hartigh AB; Tsolis RM; Adams LG; Davis DS; Ficht TA
Vaccine; 2006 Jun; 24(24):5169-77. PubMed ID: 16697090
[TBL] [Abstract][Full Text] [Related]
57. [Preliminary study of two inbred mice models for infection and immunity of Brucellosis].
Zhang JL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):18-24. PubMed ID: 2527626
[TBL] [Abstract][Full Text] [Related]
58. Brucella melitensis: a nasty bug with hidden credentials for virulence.
Moreno E; Moriyon I
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):1-3. PubMed ID: 11782541
[No Abstract] [Full Text] [Related]
59. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
60. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
